Clinical Trial

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Study acronym: NEXUS
Recruiting
View on ClinicalTrials.gov →
Summary
This study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-30
notable Trial sites expanded: 0 -> 9 locations 2026-07-30
Trial Details
NCT Number NCT07227805
Lead Sponsor Medtronic MiniMed, Inc.
Conditions Diabetes (Insulin-requiring, Type 1 or Type 2)
Enrollment 116 participants
Start Date 2026-07-19
Primary Completion 2027-03-17 (estimated)
Study Completion 2027-03-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-29